S. Vatn

发表

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome

J. Satsangi, M. Vatn, J. Jahnsen, 2021, Journal of Crohn's & colitis.

The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients

S. Heath, H. Drummond, C. Lees, 2018, Scientific Reports.

Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway

S. Frigstad, M. Høivik, G. Huppertz-Hauss, 2021, Scandinavian journal of gastroenterology.

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome

J. Satsangi, M. Vatn, J. Jahnsen, 2019, Clinical and experimental gastroenterology.

Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study

J. Jahnsen, T. E. Detlie, S. Vatn, 2015, Expert review of gastroenterology & hepatology.

Edinburgh Explorer Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease

J. Jahnsen, J. Söderholm, J. Halfvarson, 2020 .

Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2

J. Satsangi, M. Vatn, J. Ostrowski, 2022, Journal of Crohn's & colitis.

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

Fredrik Dahl, S. Heath, H. Drummond, 2016, Nature Communications.

Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy

M. Vatn, J. Jahnsen, T. Tannæs, 2016, BMC Research Notes.

Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy

M. Vatn, J. Jahnsen, T. Tannæs, 2016, BMC Research Notes.

Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease.

J. Satsangi, A. Ivens, J. Jahnsen, 2020, Journal of Crohn's & colitis.

The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients

M. Vatn, J. Jahnsen, T. Tannæs, 2018, Scientific Reports.

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort

J. Satsangi, M. Vatn, J. Jahnsen, 2022, Clinical and experimental gastroenterology.

Epigenetic Alterations at Diagnosis Predict Susceptibility, Prognosis and Treatment Escalation in Inflammatory Bowel Disease and IBD Character

E. Nimmo, J. Satsangi, M. Vatn, 2017 .

Patients’ perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey*

J. Jahnsen, R. Kalla, F. Gomollón, 2018, Scandinavian journal of gastroenterology.

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

J. Satsangi, D. Repsilber, M. D’Amato, 2020, bioRxiv.

AODTH-008 Proximity extension assay based proteins show immune cell specificity and can diagnose and predict outcomes in inflammatory bowel diseases: ibd character study

J. Satsangi, J. Jahnsen, J. Halfvarson, 2017, Gut.

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

J. Satsangi, M. Vatn, J. Jahnsen, 2020, Scandinavian journal of gastroenterology.

Fatigue in patients with newly diagnosed inflammatory bowel disease: Results from a prospective inception cohort, the IBSEN III study.

S. Frigstad, M. Høivik, G. Huppertz-Hauss, 2023, Journal of Crohn's & colitis.